Articles

Crunching the numbers on Obamacare

The biggest changes from President Obama’s 2010 health reform law take effect nine months from now, so many Hoosier employers have started crunching detailed numbers to cost out their options.

Read More

Deal raises hopes for Healthy Indiana Plan expansion

Gov. Mike Pence’s strategy for expanding Medicaid in Indiana is to convince or cajole the Obama administration to let him use the Healthy Indiana Plan to do it. A recent deal in Arkansas seems to make it more likely that the Obama team will give Pence what he wants.

Read More

State ties higher ed funding to results

With fewer state dollars coming with more strings, Indiana’s public universities are altering their strategies in big and small ways to receive as much money as possible from the state.

Read More

Studies: Employers could save with Medicaid expansion

The debate over expanding Medicaid in Indiana so far has hinged on how much it will cost. But two recent studies suggest Hoosier employers should be focused on how much a Medicaid expansion will save them: perhaps as much as $400 million per year.

Read More

Profits at center of biosimilars debate

House Bill 1315, which is scheduled for a Senate floor hearing on Monday, would require pharmacists to check with a patient’s physician before automatically substituting a generic version of a biotech drug for a brand-name version.

Read More

Profits at stake in fight over generic biotech drugs

House Bill 1315, which is scheduled for a Senate floor hearing on Monday, would require pharmacists to check with a patient’s physician before automatically substituting a generic version of a biotech drug for a brand-name version.

Read More

ITT fights to stem tumbling enrollment

A federal investigation and a shareholder lawsuit are the latest headwinds to threaten ITT Educational Services Inc., which is trying to reverse a precipitous decline in enrollment.

Read More

Q&A

Mike Sherman, the chief financial officer at West Lafayette-based Endocyte Inc., talked about how the drug firm’s funding partnership with New Jersey-based Merck & Co. Inc. has helped accelerate development of the company’s pipeline, which is branching out into drugs to treat cancers of the lung, prostate and breast.

Read More

IU Health puts Methodist expansion plans on hold

Citing concerns about the economy and federal health reform, Indiana University Health has pressed pause on its plans to build a bed tower at Methodist Hospital that could have cost it as much as $500 million.

Read More

Menard ousts Hilbert from investment firm

Steve Hilbert has been ousted as CEO of Indianapolis-based MH Private Equity after a bitter battle with John Menard, the hardware store king who financed the $500 million private equity firm.

Read More
rop-hospital-031113-2col.jpg

Sequester won’t batter Indianapolis hospitals

As President Obama said, the pain of the federal sequester will be real. But when it comes to hospitals, how real and how painful depends on where they are and how big they are. While rural hospitals face sharp reductions in their operating margins, most of the four major hospital systems that operate in Indianapolis […]

Read More